INTRAVENOUS ANTIBIOTIC USAGE IN HIGH-RISK PATIENTS COMPARED TO FDA-APPROVED USAGE

被引：12

作者：

GIBSON, JT

HANLEY, EE

NEWTON, DS

机构：

[1] AUBURN UNIV, AUBURN, AL 36830 USA

[2] ST JOSEPH HOSP, HOUSTON, TX 77002 USA

[3] UNIV HOUSTON, HOUSTON, TX 77004 USA

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1973年 / 30卷 / 02期

关键词：

D O I：

10.1093/ajhp/30.2.116

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：116 / 123

页数：8

共 25 条

[1] ADRIANI J, 1969, JAMA-J AM MED ASSOC, V207, P1335
[2] ARTZ CP, 1967, COMPLICATIONS SURGER, P29
[3] BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
[4] FAILURE OF CHILDREN TO RECEIVE PENICILLIN BY MOUTH
BERGMAN, AB
WERNER, RJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1963, 268 (24) : 1334 - &
[5] DONE AA, 1960, J ADVERTISING RES, V1, P18
[6] EDWARDS AL, 1968, EXPERIMENTAL DESIGN, P200
[7] FRANCKE DE, 1969, DRUG INTEL CLIN PHAR, V3, P237
[8] GARROD LP, 1963, ANTIBIOT CHEMOTHER, P338
[9] GOODMAN LS, 1970, PHARMACOL BASIS, P1167
[10] JACO G, 1958, PATIENTS PHYSICIANS, P372